The board of CSPC PHARMA (01093) has announced a share award. On June 8, 2026, the company granted a total of 1.35 million restricted shares to two selected participants from the group under its 2018 Share Award Scheme.
The grant was made free of charge, but its effectiveness is conditional upon acceptance by the grantees and the fulfillment of specific vesting conditions and performance targets.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments